These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 25822687)

  • 1. Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Seo N; Byun JH; Kim JH; Kim HJ; Lee SS; Song KB; Kim SC; Han DJ; Hong SM; Lee MG
    Ann Surg; 2016 Mar; 263(3):557-64. PubMed ID: 25822687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative nomogram predicting malignant potential in the patients with intraductal papillary mucinous neoplasm of the pancreas: focused on imaging features based on revised international guideline.
    Hwang JA; Choi SY; Lee JE; Kim SS; Lee S; Moon JY; Heo NH
    Eur Radiol; 2020 Jul; 30(7):3711-3722. PubMed ID: 32095876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
    Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
    J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.
    Kang MJ; Jang JY; Lee S; Park T; Lee SY; Kim SW
    World J Surg; 2015 Aug; 39(8):2006-13. PubMed ID: 25894399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary mucinous neoplasm of the pancreas: diagnostic performance of the 2017 international consensus guidelines using CT and MRI.
    Min JH; Kim YK; Kim SK; Kim H; Ahn S
    Eur Radiol; 2021 Jul; 31(7):4774-4784. PubMed ID: 33409798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thirty years of experience with intraductal papillary mucinous neoplasm of the pancreas: from discovery to international consensus.
    Tanaka M
    Digestion; 2014; 90(4):265-72. PubMed ID: 25591885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
    Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
    Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
    Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
    Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison with surgically resected mucinous cystic neoplasm of pancreas and branch-duct type intraductal papillary mucinous neoplasm considering clinico-radiological high-risk features: a reassessment of current guidelines.
    Kim H; Kim JH; An J; Choi JS
    Abdom Radiol (NY); 2024 Aug; 49(8):2746-2755. PubMed ID: 38744705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas?
    Niiya F; Ohike N; Norose T; Takano Y; Azami T; Kobayashi T; Maruoka N; Wakabayashi T; Matsuo K; Tanaka K; Nagahama M
    Pancreatology; 2020 Oct; 20(7):1379-1385. PubMed ID: 32873485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Malignancy in "Pure" Branch-Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Enhancing Mural Nodules on CT Imaging: A Nationwide Multicenter Study.
    Kim TH; Woo YS; Chon HK; Hwang JH; Yoo KS; Lee WJ; Lee KH; Lee JK; Dong SH; Park CH; Park ET; Moon JH; Kim HG; Cho KB; Kim HJ; Lee SO; Cheon YK; Lee JM; Park JW; Kim MH
    Gut Liver; 2018 Sep; 12(5):583-590. PubMed ID: 29730906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases.
    Nara S; Onaya H; Hiraoka N; Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T
    Pancreas; 2009 Jan; 38(1):8-16. PubMed ID: 18665010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis of benign and malignant branch duct intraductal papillary mucinous neoplasm using contrast-enhanced endoscopic ultrasonography.
    Harima H; Kaino S; Shinoda S; Kawano M; Suenaga S; Sakaida I
    World J Gastroenterol; 2015 May; 21(20):6252-60. PubMed ID: 26034360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraductal papillary mucinous neoplasm of the pancreas].
    Rosendahl J; Mössner J
    Dtsch Med Wochenschr; 2014 May; 139(17):894-7. PubMed ID: 24760694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medical management of intraductal papillary mucinous neoplasm].
    Kim YT
    Korean J Gastroenterol; 2008 Oct; 52(4):214-9. PubMed ID: 19077522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula.
    Hwang DW; Jang JY; Lim CS; Lee SE; Yoon YS; Ahn YJ; Han HS; Kim SW; Kim SG; Yun YK; Han SS; Park SJ; Lim TJ; Kang KJ; Sim MS; Choi SH; Heo JS; Choi DW; Hur KY; Lee DS; Yun SS; Kim HJ; Cho CK; Kim HJ; Yu HC; Cho BH; Song IS
    J Korean Med Sci; 2011 Jun; 26(6):740-6. PubMed ID: 21655058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.